Correlation Between Valneva SE and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Valneva SE and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and ABVC Biopharma, you can compare the effects of market volatilities on Valneva SE and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and ABVC Biopharma.
Diversification Opportunities for Valneva SE and ABVC Biopharma
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Valneva and ABVC is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Valneva SE i.e., Valneva SE and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Valneva SE and ABVC Biopharma
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the ABVC Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.41 times less risky than ABVC Biopharma. The stock trades about -0.23 of its potential returns per unit of risk. The ABVC Biopharma is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 52.00 in ABVC Biopharma on September 13, 2024 and sell it today you would lose (3.49) from holding ABVC Biopharma or give up 6.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. ABVC Biopharma
Performance |
| Timeline |
| Valneva SE ADR |
| ABVC Biopharma |
Valneva SE and ABVC Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and ABVC Biopharma
The main advantage of trading using opposite Valneva SE and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.| Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |